ASML Financial Guidance Includes Terafab Plans, CFO Says
📊 GOOGL — Piyasa Yorumu
▲ up · 60%Although GOOGL shares rose 4.2% in the last close and the RSI at 67 is approaching overbought territory, the MACD remaining above its signal line and trading above the 20- and 50-day moving averages support short-term upward momentum. ASML's positive guidance regarding its terafab plans is boosting optimism in the semiconductor sector, which could indirectly benefit technology stocks like GOOGL. However, the elevated RSI level and the recent sharp rally also bring some risk of profit-taking in the near term. Therefore, while the upward trend persists, caution is advisable.
📊 ASML — Piyasa Yorumu
▲ up · 65%The news headline indicates that ASML's Terafab plans are included in the financial guidance and were disclosed by the CFO. This can be interpreted as a positive signal for the company's growth potential. Technical indicators also support this view: the RSI is trending upward at 62, the MACD is above the signal line, and the price is above both the 20-day and 50-day moving averages. However, with the price rising 1.2% from the last close and the RSI not approaching overbought territory, the upward movement may continue in the short term. Nevertheless, since it is uncertain whether the market has fully priced in the news, the confidence level is assessed as medium-high.